$GNPX News Article - Genprex Announces Initiation of its Phase 1/2 Acclaim-1 Clinical Trial for REQORSA(TM) Immunogene Therapy in Combination with Tagrisso to Treat Non-Small Cell Lung Cancer Following FDA Review
https://marketwirenews.com/news-releases/genp...26244.html